Zinc has reported to play a neuroprotective role in the development of
spinal cord injury (SCI). The protective mechanism of
zinc remains to be uncovered. The aim of the current study was to investigate the neuroprotective mechanism of
zinc in the progression of SCI. The C57BL/6J mouse SCI model was established to confirm the protective role of
zinc in vivo, while the cellular model was induced in mouse microglial BV2 cells by using
lipopolysaccharide (LPS). The expression levels of XIST, miR-374a-5p and NLRP3
inflammasome as well as the
autophagy-related proteins were detected using real-time PCR and immunoblotting. Cell viability was assessed by
CCK-8 assay. Apoptosis was evaluated by TUNEL staining, flow cytometry, the determination of apoptosis-related
proteins. The target relationship was confirmed by
luciferase reporter assays.
Zinc improved locomotor function in SCI mice and alleviated LPS-induced BV2 cell
injuries by inhibiting apoptosis and initiating autophagy processes. XIST and NLRP3
inflammasome was upregulated while miR-374a-5p was downregulated in spinal cords of SCI mice and LPS-treated BV2 cells. All these effects were inhibited by
Zinc treatment. XIST knockdown triggered microglial autophagy-mediated NLRP3 inactivation in LPS-induced BV2 cells by regulating miR-374a-5p.
Zinc treatment protected BV2 cells from LPS-induced cell injury by the downregulation of XIST. This process might be through autophagy‑mediated NLRP3
inflammasome inactivation by targeting miR-374a-5p.
Zinc downregulates XIST and induces
neuroprotective effects against SCI by promoting microglial autophagy-induced NLRP3
inflammasome inactivation through regulating miR-374a-5p. Our finding provides novel opportunities for the understanding of
zinc-related
therapy of SCI.